Biliary Atresia Study in Infants and Children

ID#: NCT00345553

Age: 6 months - 20 years

Gender: All

Healthy Subjects: No

Recruitment Status: Recruiting

Start Date: May 01, 2006

End Date: May 01, 2024

Contact Information:
Terese A Howell, BS
734-476-5340
Sayori Suda-Wilson, BS, RD
734-678-5070
Summary: Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To identify polymorphisms that may be important in disease progression such as HLA polymorphisms; To characterize the natural history of the older, non-transplanted child with BA.
Eligibility:

Inclusion Criteria:

1. Participants need to have a confirmed diagnosis of BA determined by chart review including review of pertinent diagnostic biopsy reports, radiologic reports and surgical reports (if surgery was performed).

2. Participants need to be >6 months of age up to and equal to the age of 20 (participants enrolled at 20 years of age will have one visit).

3. Participants either have their native liver or have a confirmed liver transplantation.

4. Parent, guardian or participant (if 18 years of age or older) is willing to provide informed consent and, when appropriate, the participant is willing to assent.

Exclusion Criteria:

1. Currently participating in the ChiLDReN study PROBE

2. Inability to confirm original diagnostic evaluation of biliary atresia

3. Inability or unwillingness of family or participant to participate in all scheduled visits.
Find a Clinical Trial